PMGC HOLDINGS INC. Investment Income, Investment Expense
PMGC HOLDINGS INC. (ELAB) reported Investment Income, Investment Expense of $23.54 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInvestmentExpense · last filed 2024-05-15
- PMGC HOLDINGS INC. investment income, investment expense for the quarter ending 2024-03-31 was $23.54K, a 792.91% increase year-over-year.
- PMGC HOLDINGS INC. investment income, investment expense for the quarter ending 2023-03-31 was $2.64K.
| Period end | Investment Income, Investment Expense 3 month |
|---|---|
| 2024-03-31 | $23.54K 10-Q · filed 2024-05-15 |
| 2023-03-31 | $2.64K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |